{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T02:20:29Z","timestamp":1720146029360},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81402940","31370899"],"award-info":[{"award-number":["81402940","31370899"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Natural Science Foundation of Jiangsu Province, China","award":["BK20140615"],"award-info":[{"award-number":["BK20140615"]}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2014HP062"],"award-info":[{"award-number":["ZR2014HP062"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.lfs.2015.11.023","type":"journal-article","created":{"date-parts":[[2015,11,24]],"date-time":"2015-11-24T07:30:13Z","timestamp":1448350213000},"page":"129-137","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Benzenediamine analog FC-99 inhibits TLR2 and TLR4 signaling in peritoneal macrophage in vitro"],"prefix":"10.1016","volume":"144","author":[{"given":"Liu","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan","family":"Dou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxian","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yayi","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9573","key":"10.1016\/j.lfs.2015.11.023_bb0005","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/S0140-6736(07)60751-X","article-title":"Inflammatory bowel disease: clinical aspects and established and evolving therapies","volume":"369","author":"Baumgart","year":"2007","journal-title":"Lancet"},{"issue":"21","key":"10.1016\/j.lfs.2015.11.023_bb0010","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1056\/NEJMra0804647","article-title":"Inflammatory bowel disease","volume":"361","author":"Abraham","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.lfs.2015.11.023_bb0015","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1053\/j.gastro.2004.01.007","article-title":"Mechanisms of cross hyporesponsiveness to Toll-like receptor bacterial ligands in intestinal epithelial cells","volume":"126","author":"Otte","year":"2004","journal-title":"Gastroenterology"},{"issue":"7152","key":"10.1016\/j.lfs.2015.11.023_bb0020","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/nature06005","article-title":"Unravelling the pathogenesis of inflammatory bowel disease","volume":"448","author":"Xavier","year":"2007","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.lfs.2015.11.023_bb0025","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nprot.2007.41","article-title":"Chemically induced mouse models of intestinal inflammation","volume":"2","author":"Wirtz","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.lfs.2015.11.023_bb0030","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1146\/annurev-immunol-030409-101225","article-title":"Inflammatory bowel disease","volume":"28","author":"Kaser","year":"2010","journal-title":"Annu. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.lfs.2015.11.023_bb0035","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.cell.2004.07.002","article-title":"Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis","volume":"118","author":"Rakoff-Nahoum","year":"2004","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.lfs.2015.11.023_bb0040","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/mi.2013.13","article-title":"The role of pattern recognition receptors in intestinal inflammation","volume":"6","author":"Fukata","year":"2013","journal-title":"Mucosal Immunol."},{"issue":"2","key":"10.1016\/j.lfs.2015.11.023_bb0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009125","article-title":"The induction of colitis and ileitis in mice is associated with marked increases in intestinal concentrations of stimulants of TLRs 2, 4, and 5","volume":"5","author":"Erridge","year":"2010","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.lfs.2015.11.023_bb0050","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1053\/gast.2002.33662","article-title":"Toll-like receptors 2 and 4 are up-regulated during intestinal inflammation","volume":"122","author":"Hausmann","year":"2002","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.lfs.2015.11.023_bb0055","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1136\/gut.2006.104497","article-title":"Exacerbation of murine ileitis by Toll-like receptor 4 mediated sensing of lipopolysaccharide from commensal Escherichia coli","volume":"56","author":"Heimesaat","year":"2007","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.lfs.2015.11.023_bb0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0000662","article-title":"Shift towards pro-inflammatory intestinal bacteria aggravates acute murine colitis via Toll-like receptors 2 and 4","volume":"2","author":"Heimesaat","year":"2007","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.lfs.2015.11.023_bb0065","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.4049\/jimmunol.170.8.3977","article-title":"Strategic compartmentalization of Toll-like receptor 4 in the mouse gut","volume":"170","author":"Ortega-Cava","year":"2003","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.lfs.2015.11.023_bb0070","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1365-2249.2007.03531.x","article-title":"Increased expression of Toll-like receptor (TLR) 2 and TLR4 in the colonic mucosa of children with inflammatory bowel disease","volume":"151","author":"Szebeni","year":"2008","journal-title":"Clin. Exp. Immunol."},{"issue":"10","key":"10.1016\/j.lfs.2015.11.023_bb0075","doi-asserted-by":"crossref","first-page":"6416","DOI":"10.4049\/jimmunol.174.10.6416","article-title":"A synthetic TLR4 antagonist has anti-inflammatory effects in two murine models of inflammatory bowel disease","volume":"174","author":"Fort","year":"2005","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.lfs.2015.11.023_bb0080","doi-asserted-by":"crossref","first-page":"G1167","DOI":"10.1152\/ajpgi.90496.2008","article-title":"A novel Toll-like receptor 4 antagonist antibody ameliorates inflammation but impairs mucosal healing in murine colitis","volume":"296","author":"Ungaro","year":"2009","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"27","key":"10.1016\/j.lfs.2015.11.023_bb0085","doi-asserted-by":"crossref","first-page":"4280","DOI":"10.3748\/wjg.14.4280","article-title":"Role of cytokines in inflammatory bowel disease","volume":"14","author":"Sanchez-Munoz","year":"2008","journal-title":"World J. Gastroenterol."},{"issue":"6","key":"10.1016\/j.lfs.2015.11.023_bb0090","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.immuni.2012.08.026","article-title":"Ly6C hi monocytes in the inflamed colon give rise to proinflammatory effector cells and migratory antigen-presenting cells","volume":"37","author":"Zigmond","year":"2012","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.lfs.2015.11.023_bb0095","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/mi.2010.75","article-title":"Immunoregulatory mechanisms of macrophage PPAR-gamma in mice with experimental inflammatory bowel disease","volume":"4","author":"Hontecillas","year":"2011","journal-title":"Mucosal Immunol."},{"issue":"2","key":"10.1016\/j.lfs.2015.11.023_bb0100","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.immuni.2006.06.010","article-title":"Role of Toll-like receptors in spontaneous commensal-dependent colitis","volume":"25","author":"Rakoff-Nahoum","year":"2006","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.lfs.2015.11.023_bb0105","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.jtbi.2010.03.027","article-title":"Model of colonic inflammation: immune modulatory mechanisms in inflammatory bowel disease","volume":"264","author":"Wendelsdorf","year":"2010","journal-title":"J. Theor. Biol."},{"issue":"12","key":"10.1016\/j.lfs.2015.11.023_bb0110","doi-asserted-by":"crossref","first-page":"4388","DOI":"10.1128\/IAI.00530-12","article-title":"Systemic macrophage depletion inhibits Helicobacter bilis-induced proinflammatory cytokine-mediated typhlocolitis and impairs bacterial colonization dynamics in a BALB\/c Rag2\u2212\/\u2212 mouse model of inflammatory bowel disease","volume":"80","author":"Muthupalani","year":"2012","journal-title":"Infect. Immun."},{"issue":"2","key":"10.1016\/j.lfs.2015.11.023_bb0115","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1053\/gast.2001.26279","article-title":"The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study","volume":"121","author":"Faubion","year":"2001","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.lfs.2015.11.023_bb0120","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1002\/ibd.22837","article-title":"Analysis of current treatments used in clinical practice in a pediatric summer camp population for children with inflammatory bowel disease","volume":"18","author":"Rosen","year":"2012","journal-title":"Inflamm. Bowel Dis."},{"issue":"6","key":"10.1016\/j.lfs.2015.11.023_bb0125","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1053\/j.gastro.2004.02.070","article-title":"Optimizing anti-TNF treatment in inflammatory bowel disease","volume":"126","author":"Rutgeerts","year":"2004","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.lfs.2015.11.023_bb0130","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.cgh.2006.03.002","article-title":"Serious infections and mortality in association with therapies for Crohn's disease: TREAT registry","volume":"4","author":"Lichtenstein","year":"2006","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.lfs.2015.11.023_bb0135","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1165\/rcmb.2013-0411OC","article-title":"A novel benzenediamine derivate rescued mice from experimental sepsis by attenuating proinflammatory mediators via IRAK4","volume":"51","author":"Dou","year":"2014","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"7","key":"10.1016\/j.lfs.2015.11.023_bb0140","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1111\/j.1476-5381.2010.00873.x","article-title":"Guidelines for reporting experiments involving animals: the ARRIVE guidelines","volume":"160","author":"McGrath","year":"2010","journal-title":"Br. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.lfs.2015.11.023_bb0145","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1053\/gast.2002.32994","article-title":"Immunostimulatory DNA ameliorates experimental and spontaneous murine colitis","volume":"122","author":"Rachmilewitz","year":"2002","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.lfs.2015.11.023_bb0150","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1084\/jem.20061082","article-title":"IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis","volume":"203","author":"Kullberg","year":"2006","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.lfs.2015.11.023_bb0155","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1172\/JCI21404","article-title":"IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6","volume":"116","author":"Yen","year":"2006","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.lfs.2015.11.023_bb0160","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.immuni.2005.10.001","article-title":"Macrophage polarization comes of age","volume":"23","author":"Mantovani","year":"2005","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.lfs.2015.11.023_bb0165","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.cell.2011.09.051","article-title":"CD14 controls the LPS-induced endocytosis of Toll-like receptor 4","volume":"147","author":"Zanoni","year":"2011","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.lfs.2015.11.023_bb0170","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1053\/j.gastro.2006.01.048","article-title":"American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease","volume":"130","author":"Lichtenstein","year":"2006","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.lfs.2015.11.023_bb0175","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/0016-5085(90)90290-H","article-title":"A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice","volume":"98","author":"Okayasu","year":"1990","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.lfs.2015.11.023_bb0180","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/ibd.20753","article-title":"Distinct cytokine patterns identified from multiplex profiles of murine DSS and TNBS-induced colitis","volume":"15","author":"Alex","year":"2009","journal-title":"Inflamm. Bowel Dis."},{"issue":"1","key":"10.1016\/j.lfs.2015.11.023_bb0185","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/ibd.21677","article-title":"Functional relevance of T helper 17 (Th17) cells and the IL-17 cytokine family in inflammatory bowel disease","volume":"18","author":"Hundorfean","year":"2012","journal-title":"Inflamm. Bowel Dis."},{"issue":"5","key":"10.1016\/j.lfs.2015.11.023_bb0190","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.molmed.2009.03.002","article-title":"CD4 T-cell differentiation and inflammatory bowel disease","volume":"15","author":"Zenewicz","year":"2009","journal-title":"Trends Mol. Med."},{"issue":"6","key":"10.1016\/j.lfs.2015.11.023_bb0195","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.bcp.2012.12.002","article-title":"Inhibition of Th1\/Th17 responses via suppression of STAT1 and STAT3 activation contributes to the amelioration of murine experimental colitis by a natural flavonoid glucoside icariin","volume":"85","author":"Tao","year":"2013","journal-title":"Biochem. Pharmacol."},{"issue":"5","key":"10.1016\/j.lfs.2015.11.023_bb0200","first-page":"471","article-title":"Expression and release of leptin and proinflammatory cytokines in patients with ulcerative colitis and infectious diarrhea","volume":"63","author":"Biesiada","year":"2012","journal-title":"J. Physiol. Pharmacol."},{"issue":"5","key":"10.1016\/j.lfs.2015.11.023_bb0205","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.immuni.2009.05.001","article-title":"Plasticity of CD4+ T cell lineage differentiation","volume":"30","author":"Zhou","year":"2009","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.lfs.2015.11.023_bb0210","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/S0016-5085(97)70030-1","article-title":"Cytokine profiles differ in newly recruited and resident subsets of mucosal macrophages from inflammatory bowel disease","volume":"112","author":"Rugtveit","year":"1997","journal-title":"Gastroenterology"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320515300862?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320515300862?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T23:21:41Z","timestamp":1692141701000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320515300862"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":42,"alternative-id":["S0024320515300862"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2015.11.023","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Benzenediamine analog FC-99 inhibits TLR2 and TLR4 signaling in peritoneal macrophage in vitro","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2015.11.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}